Clinical data | |
---|---|
Trade names | Buronil |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral, intramuscular injection |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 87% (IM), 54% (Oral via syrup), 65% (Oral, tablet)[1] |
Protein binding | 50% |
Metabolism | Hepatic |
Elimination half-life | 3–4 hours (oral)[1] 6 hours (IM) |
Excretion | Renal (70% as metabolites, 5.5–10.4% as unchanged drug)[1][2] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.107.027 |
Chemical and physical data | |
Formula | C16H22FNO |
Molar mass | 263.356 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Melperone (Bunil (PT), Buronil (AT, BE, CZ, DK, FI†, NL†, NO†, SE), Eunerpan (DE))[3] is an atypical antipsychotic of the butyrophenone chemical class, making it structurally related to the typical antipsychotic haloperidol. It first entered clinical use in 1960s.[4]
I1
was invoked but never defined (see the help page).MD
was invoked but never defined (see the help page).Audit
was invoked but never defined (see the help page).